Key Takeaway
When your compounded medication arrives, the label on that vial tells you a lot about the pharmacy behind it. Understanding compounded medication labeling requirements helps you verify that your medication is legitimate, properly prepared, and safe to use.
When your compounded medication arrives, the label on that vial tells you a lot about the pharmacy behind it. Understanding compounded medication labeling requirements helps you verify that your medication is legitimate, properly prepared, and safe to use.
Key Takeaways: - Required Label Elements for Compounded Medications - Understand what each label element tells you about quality - Common Labeling Problems and What They Mean - Learn how to read your glp-1 medication label
This guide walks you through every element that should be on your compounded medication label and what to do if something is missing.
Required Label Elements for Compounded Medications
State boards of pharmacy and USP standards require specific information on every compounded medication label. While exact requirements vary slightly by state, the core elements are consistent.
Patient name. Your name should appear on the label. This confirms the medication was compounded for you specifically, based on your provider's prescription. If your name isn't on the label, that's a problem.
Prescriber name. The name of the healthcare provider who wrote your prescription should be listed. This creates a chain of accountability from provider to pharmacy to patient.
Drug name and strength. The label must clearly state the active ingredient and its concentration or strength. For example, "Semaglutide 5mg/mL" tells you exactly what's in the vial and how much per milliliter.
Quantity. The total volume or quantity of medication in the container. This might read "2mL" or "5mL" for an injectable vial.
Beyond-use date (BUD). This is the date after which the medication shouldn't be used. It's different from a manufacturer's expiration date. Compounded medications typically have shorter beyond-use dates because they're prepared in smaller batches. Never use a compounded medication past this date.
"What makes tirzepatide particularly interesting is the dual GIP/GLP-1 mechanism. We're seeing that GIP receptor activation appears to amplify the metabolic effects in ways we didn't fully anticipate from the preclinical data.") Dr. Ania Jastreboff, MD, PhD, Yale School of Medicine, lead author of SURMOUNT-1[1]
Storage instructions. Your label should tell you how to store the medication. Most compounded injectables, including , require refrigeration.
Pharmacy name and address. The licensed compounding pharmacy's name and physical address must appear on the label. This lets you verify the pharmacy's licensing status.
What Each Label Element Tells You About Quality
The label isn't just a legal requirement (it's a quality indicator. Here's what to read between the lines.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
A complete label signals compliance. If every required element is present, clearly printed, and accurate, it suggests the pharmacy follows established protocols. Sloppy or incomplete labeling often correlates with sloppy compounding practices.
The beyond-use date tells you about testing. Pharmacies that perform stability testing can assign longer beyond-use dates. A very short BUD (a few days) on a product that should be stable longer might indicate the pharmacy hasn't done stability testing. A BUD that seems excessively long might indicate the pharmacy is assigning dates without supporting data.
Concentration formatting matters. The strength should be expressed in standard pharmaceutical notation) mg/mL for injectables, for example. Unusual or ambiguous strength descriptions can indicate a lack of pharmaceutical expertise.
Lot or batch numbers enable traceability. While not required in every state, lot numbers allow the pharmacy to trace your medication back to specific ingredient batches and preparation records. If a problem is discovered later, this number is how they track which patients were affected.
If you're managing a , proper labeling helps you keep track of exactly what you're using and when it expires.
Free Download: Compounding Pharmacy Verification Checklist This printable checklist includes a label verification section you can use to check every medication you receive. Get yours free (we'll email it to you instantly. [Email Input] [Download Button]
Common Labeling Problems and What They Mean
Not all labeling issues are equally serious. Here's how to evaluate common problems.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Missing patient name. This could mean the medication wasn't prepared for you specifically. Under 503A compounding rules, medications must be patient-specific. A missing name raises questions about whether a valid prescription was involved.
No beyond-use date. This is a significant safety concern. Without a BUD, you have no way to know if the medication has degraded. Degraded medications may be less effective or potentially harmful. Don't use a compounded medication without a beyond-use date.
Vague strength information. If the label says something like "semaglutide solution" without a specific concentration, you can't verify your dose. This is both a safety issue and a sign of poor pharmacy practices.
No pharmacy information. If there's no pharmacy name or address on the label, you can't verify the source. This is a major red flag. Legitimate pharmacies are proud to put their name on their work.
Handwritten labels. While not automatically disqualifying, handwritten labels on injectable medications are unusual for established compounding pharmacies. Most use professional label printing systems. Handwriting increases the risk of errors and is harder to read.
Misspellings or errors. Spelling mistakes on a pharmaceutical label indicate a lack of quality controls. If the pharmacy doesn't catch errors on the label, what else are they missing?
If you receive a medication with any of these issues, contact the pharmacy and your prescribing provider before using it. You can also to discuss your concerns.
How to Read Your GLP-1 Medication Label
Let's walk through a practical example of reading a compounded GLP-1 medication label.
A properly labeled vial of compounded semaglutide should include:
- Your name) confirms it was prescribed for you
- "Semaglutide [X] mg/mL", the active ingredient and its concentration per milliliter
- Total volume, such as "2 mL", tells you how much is in the vial
- "Subcutaneous injection", the route of administration
- Beyond-use date, the last date you should use this medication
- "Store refrigerated 2-8°C", or similar storage instructions
- Pharmacy name, address, and phone number, who made it
- Prescriber name, who prescribed it
- Lot number, for traceability
- "Rx Only", confirms it's a prescription medication
Some labels also include auxiliary warnings like "Protect from light" or "Shake gently before use" if applicable to the formulation.
Understanding your label helps you use your medication safely and gives you confidence in its source. For help tracking your doses and protocol, try the , it logs doses, visualizes medication levels, and keeps your treatment organized.
Frequently Asked Questions
What's the difference between a beyond-use date and an expiration date?
An expiration date applies to commercially manufactured medications and is based on extensive stability testing. A beyond-use date (BUD) applies to compounded medications and indicates when the preparation should no longer be used. BUDs are typically shorter than expiration dates and are determined based on USP guidelines and the pharmacy's stability data.
Should my compounded medication have a lot number?
While not required in all states, lot numbers are a best practice. They enable the pharmacy to trace your medication back to specific ingredients and preparation records. Pharmacies that assign lot numbers typically have more well-tested quality systems.
Can I request a new label if mine is damaged or hard to read?
Yes. Contact your compounding pharmacy and ask for a replacement label. A damaged or illegible label is a safety concern because you may not be able to read critical information like the beyond-use date or concentration. Don't use a medication with an unreadable label.
What should I do if my label information doesn't match my prescription?
Don't use the medication. Contact the pharmacy immediately to resolve the discrepancy. Also notify your prescribing provider. A mismatch between your prescription and the medication label could indicate a dispensing error.
Are labeling requirements the same in every state?
Core labeling requirements are similar across states, but specific requirements can vary. Some states require additional information such as the date dispensed, number of refills remaining, or specific auxiliary warnings. Your state board of pharmacy's regulations define the exact requirements for your state.
Ready to Take the Next Step?
Your treatment plan is personal (and you deserve a plan that fits. FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol.
Medical References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
- Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.
Last updated: 2026-03-24
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →